Key improvements as compared to humanized mice and other existing in vitro systems used to study adaptive immune responses include 3D follicle formation, expression of AID and CXCL13, plasma cell formation, antigen‐specific IgG Ab generation, and production of clinically relevant cytokines in response to multiple antigens, including a commercial influenza vaccine. This evidence concerns the gene CXCL13 and influenza.